Skip to main content
Clinical Trials/TCTR20170724002
TCTR20170724002Not yet recruitingPhase 3

The randomized controlled trial of risperidone in reduction for the incidence of postoperative delirium in patients undergoing vascular surgery

Faculty of Medicine Siriraj Hospital, Mahidol University0 sites150 target enrollmentStarted: July 24, 2017Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
60 Years to 0 N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • 1. Patients are equal or older than 60 years old.
  • 2. Vascular patient that have plan to operate (aorta, carotid and peripheral) who get anesthesia more than 2 hours.
  • 3. Elective case

Exclusion Criteria

  • 1. Patients have cognitive impairment before surgery who get less than 24 score of Thai Mental State Examination (TMSE)
  • 2. Patients who regularly drink alcoholic beverages and drink within the 14 days before surgery.
  • 3. Pre-operative patients who have positive delirium when test with Confusion Assessment Method for Intensive Care Unit (CAM-ICU)
  • 4. Patients with creatinine clearance < 30 ml/min
  • 5. Patients with hepatic impairment with Child Pugh score greater than 10
  • 6. Patients with history of risperidone allergy or history of neuroleptic malignant syndrome
  • 7. Emergency case

Investigators

Sponsor
Faculty of Medicine Siriraj Hospital&#44; Mahidol University

Similar Trials